Stefan Catsicas
Stefan Catsicas | |
|---|---|
 | |
| Born | November 23, 1958 |
| Nationality | Swiss |
| Alma mater | University of Lausanne, École Polytechnique Fédérale of Lausanne, King Abdullah University of Science & Technology of Djeddah |
| Scientific career | |
| Fields | Biology, Neurosciences, Pharmaceutical |
Stefan Catsicas, born in 1958, is a Swiss molecular biologist specialised in neurosciences of Italian and Greek origins. He was executive director of Nestlé from 2013 to 2018, vice-president of research of the Ecole Polytechnique Fédérale in Lausanne (EPFL) from 2000 to 2004 and director of the institute of cell biology at the School of Medicine in Lausanne from 1996 à 2000. He is currently the managing partner of Skyviews Life Science, a Swiss advisory company in life sciences; and the director of Precision Health Corp., a private investment company based in the Isle of Man.
Early life and education
[edit]Stefan Catsicas started his scientific training with studies in natural sciences at the University of Lausanne, and a doctoral thesis on the development of the nervous system..,[1] which he obtained in 1987. He then continued his studies in this field at the Research Institute of Scripps Clinic in San Diego, California.
Career
[edit]Back in Switzerland, he became Head of the Neurobiology Department of Glaxo in Geneva from 1991 to 1996, before pursuing his academic career at the University of Lausanne as professor and chair of Cell Biology, and then as professor of Cellular Engineering at the EPFL.
In 2000, Patrick Aebischer appointed him Vice President of Research at the EPFL.[2][3] To promote pluridisciplinarity on campus, he led the collaborations with Alinghi for the America's Cup, and with Solar Impulse for the world tour with a solar-energy powered plane.[4][5][6][7]
In 2004, he left his position at the EPFL[8] and co-founded Tilocor Life Science, a biotechnology group of private companies.
In 2011, Catsicas became Provost and Executive Vice-president of the King Abdullah University of Science & Technology.[9]
In 2013, he was appointed to the executive board of Nestlé Global, as Chief Technology Officer (CTO), a position he held from 2013 to 2018 [10][11][12]
In 2018, he published his first novel in French, La Séquence (Editions Favre) which sets in the field of genetic research.[13][14]
Since 2018, Stefan Catsicas is the managing director of Skyviews Life Science,[15] a Swiss advisory company in life sciences, including biotechnology, advanced nutrition and digital health.[16] He is also the co-founder and director of the private investment company Precision Health Corp., based in the Isle of Man.
References
[edit]- ^ Catsicas, Stefan. "Record #231687". Patrinum. Retrieved 2022-10-17.
- ^ "Direction de l'EPFL: victoire de Patrick Aebischer". SWI swissinfo.ch (in French). Retrieved 2022-10-17.
- ^ "Nestle names cell scientist Catsicas as technology chief". Reuters. 2013-06-14. Retrieved 2022-10-28.
- ^ "Alinghi mise sur son partenariat avec l'EPFL pour remporter la Coupe de l'America". Le Temps (in French). 2001-10-10. ISSN 1423-3967. Retrieved 2022-10-17.
- ^ "Alinghi brings America's Cup to Europe". SWI swissinfo.ch. Retrieved 2022-10-28.
- ^ "Après le vent, Piccard s'attaque au Soleil". SWI swissinfo.ch (in French). Retrieved 2022-10-17.
- ^ "Piccard launches solar adventure". SWI swissinfo.ch. Retrieved 2022-10-28.
- ^ "Stefan Catsicas quitte la direction de l'EPFL". Le Temps (in French). 2004-08-05. ISSN 1423-3967. Retrieved 2022-10-17.
- ^ "Stefan Catsicas (auteur de La séquence)". Babelio (in French). Retrieved 2022-10-17.
- ^ "Nestlé veut repousser les frontières de l'alimentation". Le Temps (in French). 2016-05-19. ISSN 1423-3967. Retrieved 2022-10-17.
- ^ ""Nestlé sort du piège du sel et du sucre"". Bilan (in French). Retrieved 2022-10-17.
- ^ Strom, Stephanie (2016-12-01). "Nestlé Reformulates Sugar and Says It Will Use Less in Its Candy". The New York Times. ISSN 0362-4331. Retrieved 2022-10-28.
- ^ "Un thriller scientifique traque l'origine de l'humanité". Le Temps (in French). 2018-11-23. ISSN 1423-3967. Retrieved 2022-10-17.
- ^ "Le surdoué des labos manie aussi bien la plume". 24 heures (in French). Retrieved 2022-10-17.
- ^ "Skyviews Life Science". Skyviews Life Science (in French). Retrieved 2022-10-17.
- ^ "Plusieurs millions et un administrateur de renom pour Volumina Medical". Agefi.com (in French). Retrieved 2022-10-17.
